Meanwhile, Novo Nordisk is lowering drug prices and expanding patient access to semaglutide medicines, including Wegovy and Ozempic
Notably, there was a decrease in the cumulative incidence of severe albuminuria in individuals diagnosed with type 1 diabetes in the 1980s compared with those diagnosed in the 1970s in Finland, although no further improvement was apparent in the 19901999 diagnosis cohort [4]
Semaglutide burping versus other GI side effects Burping does not exist in isolation
Presented at the American Heart Associations 2023 Scientific Sessions (1113 November, Philadelphia, USA), the results of the SELECT trial showed that overweight or obese people without diabetes taking semaglutide for more than three years had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease and lost an average of 9.4% of their body weight
Finally, marketers must remain mindful of ethical considerations